0000899243-20-027723.txt : 20201007 0000899243-20-027723.hdr.sgml : 20201007 20201007170136 ACCESSION NUMBER: 0000899243-20-027723 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201005 FILED AS OF DATE: 20201007 DATE AS OF CHANGE: 20201007 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HOLMLUND JON T CENTRAL INDEX KEY: 0001227367 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39114 FILM NUMBER: 201229583 BUSINESS ADDRESS: STREET 1: 2292 FARADAY AVE CITY: CARLSBAD STATE: CA ZIP: 92008 BUSINESS PHONE: 7609319200 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Galera Therapeutics, Inc. CENTRAL INDEX KEY: 0001563577 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 461454898 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2 WEST LIBERTY BLVD #100 CITY: MALVERN STATE: PA ZIP: 19355 BUSINESS PHONE: 610-725-1500 MAIL ADDRESS: STREET 1: 2 WEST LIBERTY BLVD #100 CITY: MALVERN STATE: PA ZIP: 19355 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-10-05 0 0001563577 Galera Therapeutics, Inc. GRTX 0001227367 HOLMLUND JON T C/O GALERA THERAPEUTICS, INC., 2 W LIBERTY BLVD #100 MALVERN PA 19355 0 1 0 0 Chief Medical Officer Common Stock 2020-10-05 4 M 0 100 1.07 A 100 D Common Stock 2020-10-05 4 S 0 100 12.00 D 0 D Common Stock 2020-10-06 4 M 0 4904 1.07 A 4904 D Common Stock 2020-10-06 4 M 0 5632 1.14 A 5632 D Common Stock 2020-10-06 4 S 0 10536 12.00 D 0 D Stock Option 1.07 2020-10-05 4 M 0 100 0.00 D 2023-01-26 Common Stock 100 4904 D Stock Option 1.07 2020-10-06 4 M 0 4904 0.00 D 2023-01-26 Common Stock 4904 0 D Stock Option 1.14 2020-10-06 4 M 0 5632 0.00 D 2024-09-16 Common Stock 5632 0 D The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 18, 2019. The option has fully vested and is currently exercisable. The option has fully vested and is currently exercisable. /s/ Christopher Degnan, Attorney-in-Fact for Jon T. Holmlund 2020-10-07